Pfizer Inc.
235 East 42nd Street
New York, NY 10017
United States
212 733 2323
http://www.pfizer.com
Sector(s):Â Healthcare
Industry: Drug Manufacturers—General
Full Time Employees:Â 78,500
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Albert Bourla D.V.M., DVM, Ph.D. | Chairman & CEO | 7.99M | 1.26M | 1962 |
| Mr. John D. Young | Group Pres & Chief Bus. Officer | 3.54M | 2.82M | 1965 |
| Mr. Frank A. D'Amelio | CFO & Exec. VP of Global Supply | 4.52M | 4M | 1958 |
| Dr. Mikael Dolsten | Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical | 4.5M | N/A | 1959 |
| Ms. Angela Hwang | Group Pres of Biopharmaceuticals Group | 3.97M | 119.1k | 1966 |
| Ms. Jennifer B. Damico | Sr. VP, Controller & Principal Accounting Officer | N/A | N/A | 1968 |
| Ms. Lidia L. Fonseca | Exec. VP and Chief Digital & Technology Officer | N/A | N/A | 1969 |
| Mr. Charles E. Triano | Sr. VP of Investor Relations | N/A | N/A | N/A |
| Mr. Douglas M. Lankler | Exec. VP & Gen. Counsel | N/A | N/A | 1966 |
| Mr. Rady A. Johnson | Exec. VP and Chief Compliance, Quality & Risk Officer | N/A | N/A | 1962 |
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Corporate Governance
Pfizer Inc.’s ISS Governance QualityScore as of April 1, 2021 is 2. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 1; Compensation: 1.
